AI Article Synopsis

  • A series of 2,7-diamidofluorenones were created and tested using SRB assay, revealing some compounds with strong antitumor properties in the submicromolar range.
  • Ten compounds were highlighted in the NCI screening, with 3c showing the highest activity (GI50=1.66 μM).
  • Compound 3c also inhibited topoisomerase I, suggesting that fluorenones could be promising candidates for future anticancer drug development.

Article Abstract

A series of 2,7-diamidofluorenones were designed, synthesized, and screened by SRB assay. Some synthesized compounds exhibited antitumor activities in submicromolar range. Ten compounds (3a, 3b, 3c, 3g, 3j, 3l, 4a, 4h, 4i, and 4j) were also selected by NCI screening system and 3c (GI50=1.66 μM) appeared to be the most active agent of this series. Furthermore, 3c attenuated topoisomerase I-mediated DNA relaxation at low micromolar concentrations. These results indicated that fluorenones have potential to be further developed into anticancer drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2013.09.006DOI Listing

Publication Analysis

Top Keywords

design synthesis
4
synthesis antiproliferative
4
antiproliferative evaluation
4
evaluation fluorenone
4
fluorenone analogs
4
analogs dna
4
dna topoisomerase
4
topoisomerase inhibitory
4
inhibitory properties
4
properties series
4

Similar Publications

This study synthesises expanded graphite (EG) from graphitised carbon from waste polyethylene terephthalate (PET) bottles. The adsorbent material was characterised using FTIR, XRF, XRD, SEM, Raman Spectroscopy, and BET surface area analysis. The synthesised EG defluorinated wastewater, utilising response surface methodology (RSM) for experimental design and optimisation.

View Article and Find Full Text PDF

Background/purpose: Although metabolic dysfunction-associated steatotic liver disease (MASLD) has been proposed to replace the diagnosis of non-alcoholic fatty liver disease (NAFLD) with new diagnostic criteria since 2023, the genetic predisposition of MASLD remains to be explored.

Methods: Participants with data of genome-wide association studies (GWAS) in the Taiwan Biobank database were collected. Patients with missing data, positive for HBsAg, anti-HCV, and alcohol drinking history were excluded.

View Article and Find Full Text PDF

The Stockholm Early Detection of Cancer Study (STEADY-CAN) cohort was established to investigate strategies for early cancer detection in a population-based context within Stockholm County, the capital region of Sweden. Utilising real-world data to explore cancer-related healthcare patterns and outcomes, the cohort links extensive clinical and laboratory data from both inpatient and outpatient care in the region. The dataset includes demographic information, detailed diagnostic codes, laboratory results, prescribed medications, and healthcare utilisation data.

View Article and Find Full Text PDF

Background: Selective androgen receptor modulators (SARMs) are small-molecule compounds that exert agonist and antagonist effects on androgen receptors in a tissue-specific fashion. Because of their performance-enhancing implications, SARMs are increasingly abused by athletes. To date, SARMs have no Food and Drug Administration approved use, and recent case reports associate the use of SARMs with deleterious effects such as drug-induced liver injury, myocarditis, and tendon rupture.

View Article and Find Full Text PDF

COVID-19 has proved to be a global health crisis during the pandemic, and the emerging JN.1 variant is a potential threat. Therefore, finding alternative antivirals is of utmost priority.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!